{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:02:44Z","timestamp":1788328964183,"version":"build-2803163510"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.taap.2021.115519","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T12:28:58Z","timestamp":1617452938000},"page":"115519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat"],"prefix":"10.1016","volume":"419","author":[{"given":"Ariel","family":"Gore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Neufeld-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Egoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Baranes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rellie","family":"Gez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahav","family":"Efrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse'ela","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Dekel Jaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Yampolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettie","family":"Grauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.taap.2011.03.007","article-title":"Deterioration in brain and heart functions following a single sub-lethal (0.8 LCt50) inhalation exposure of rats to sarin vapor: a putative mechanism of the long term toxicity","volume":"253","author":"Allon","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2021.115519_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/01480549709003874","article-title":"Antagonism of soman-induced convulsions by midazolam, diazepam and scopolamine","volume":"20","author":"Anderson","year":"1997","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.taap.2021.115519_bb0015","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.114.217299","article-title":"The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats; comparison with UBP302","author":"Apland","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115519_bb0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2423(04)38006-6","article-title":"Organophosphate\/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment","volume":"38","author":"Bajgar","year":"2004","journal-title":"Adv. Clin. Chem."},{"issue":"3","key":"10.1016\/j.taap.2021.115519_bb0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuro.2012.02.002","article-title":"A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation","volume":"33","author":"Banks","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2021.115519_bb0030","first-page":"16","article-title":"Peripheral type benzodiazepine binding sites as a tool for the detection and quantification of CNS injury","volume":"7","author":"Benevides","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.taap.2021.115519_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"3\u221223","key":"10.1016\/j.taap.2021.115519_bb0040","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit. Care."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuro.2005.11.009","article-title":"Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain","volume":"27","author":"Chapman","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2021.115519_bb0050","first-page":"132","article-title":"Sarin-induced brain damage in rats is attenuated by delayed administration of midazolam","volume":"49","author":"Chapman","year":"2015","journal-title":"Neuro Toxicol."},{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","article-title":"Translocator protein 18kDA (TSPO): molecular sensor of brain injury & repair","volume":"118","author":"Chen","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2021.115519_bb0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: Pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.taap.2021.115519_bb0065","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/WNL.57.6.1036","article-title":"Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus","volume":"57","author":"Claassen","year":"2001","journal-title":"Neurology"},{"issue":"255","key":"10.1016\/j.taap.2021.115519_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.taap.2011.07.003","article-title":"Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects","volume":"15","author":"Collombet","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2021.115519_bb0075","article-title":"Mouse and rat anesthesia and analgesia","volume":"4","author":"Davis","year":"2008","journal-title":"Curr. Protoc. Neurosci. Appendix"},{"key":"10.1016\/j.taap.2021.115519_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures","volume":"53","author":"Deeb","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2021.115519_bb0085","doi-asserted-by":"crossref","first-page":"104418","DOI":"10.1016\/j.nbd.2019.03.006","article-title":"Novel therapeutics for treating organophosphate-induced status epilepticus co-morbidities, based on changes in calcium homeostasis","volume":"133","author":"Deshpande","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/nyas.14479","article-title":"Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate-induced status epilepticus in rats","volume":"1480","author":"Dhir","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.taap.2021.115519_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2021.115519_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096032719301200101","article-title":"Behavioural toxicity of anticholinesterases in humans and animals-a review","volume":"12","author":"D\u2019Mello","year":"1993","journal-title":"Hum. Exp. Toxicol."},{"issue":"10","key":"10.1016\/j.taap.2021.115519_bb0105","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1013-1194","article-title":"Syrian gas attack reinforces need for better anti-sarin drugs","volume":"19","author":"Dolgin","year":"2013","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.taap.2021.115519_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.1989.03430050065028","article-title":"Progress in medical defense against nerve agents","volume":"262","author":"Dunn","year":"1989","journal-title":"Jama"},{"key":"10.1016\/j.taap.2021.115519_bb0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(07)61202-1","article-title":"Management of acute organophosphorus pesticide poisoning","volume":"371","author":"Eddleston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2021.115519_bb0120","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/jn.01180.2007","article-title":"Alterations of GABAA-receptor function and allosteric modulation during development of status epilepticus","volume":"99","author":"Feng","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.taap.2021.115519_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0920-1211(97)00027-2","article-title":"Pharmacokinetics and muscle histopathology of intramuscular valproate","volume":"28","author":"Gallo","year":"1997","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.taap.2005.03.007","article-title":"Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats","volume":"209","author":"Gilat","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2021.115519_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.taap.2021.115519_bb0140","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2021.115519_bb0145","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/toxsci\/kfs009","article-title":"Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats","volume":"126","author":"Gore","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/toxsci\/kfv092","article-title":"Synergism between anticholinergic and Oxime treatments against sarin-induced ocular insult in rats","volume":"146","author":"Gore","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"114963","key":"10.1016\/j.taap.2021.115519_bb0160","first-page":"1","article-title":"Efficacy of retigabine in ameliorating the brain insult following sarin exposurein the rat","volume":"395","author":"Gore","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.taap.2007.11.006","article-title":"Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits","volume":"227","author":"Grauer","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2021.115519_bb0170","series-title":"Advances in Neurotoxicology: Role of Inflammation in Environmental Neurotoxicity","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/bs.ant.2018.10.003","article-title":"Organophosphates","volume":"vol. 3","author":"Guignet","year":"2019"},{"key":"10.1016\/j.taap.2021.115519_bb0175","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.taap.2021.115519_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S0317167100013160","article-title":"Status epilepticus: a review, with emphasis on refractory cases","volume":"39","author":"Hunter","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.taap.2021.115519_bb0185","series-title":"Medical Management of Chemical Casualties Handbook","author":"Hurst","year":"2007"},{"issue":"6","key":"10.1016\/j.taap.2021.115519_bb0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/10408444.2020.1787330","article-title":"A national toxicology program systematic review of the evidence for long-term effects after acute exposure to sarin nerve agent","volume":"50","author":"Jett","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.taap.2021.115519_bb0195","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/096032719501400304","article-title":"Sarin-induced neuropathology in rats","volume":"14","author":"Kadar","year":"1995","journal-title":"Hum. Exp. Toxicol."},{"issue":"Suppl Suppl 2","key":"10.1016\/j.taap.2021.115519_bb0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/epi4.12270","article-title":"Role of NMDA receptors in the pathophysiology and treatmnet of status epilepticus","volume":"3","author":"Kapur","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.taap.2021.115519_bb0205","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepineand Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2021.115519_bb0210","first-page":"1577","article-title":"NC3Rs reporting guidelines working group","volume":"160","author":"Kilkeny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115519_bb0215","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0887-8994(92)90071-6","article-title":"Midazolam in treatment of epileptic seizures","volume":"8","author":"Lahat","year":"1992","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.taap.2021.115519_bb0220","first-page":"851","article-title":"GK 11: promising additional neuroprotective therapy for organophosphate poisoning","volume":"18","author":"Lallement","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2021.115519_bb0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.taap.2016.09.008","article-title":"Propagation of damage in the rat brain following sarin exposure: differential progression of early processes","volume":"310","author":"Lazar","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"Suppl. 12","key":"10.1016\/j.taap.2021.115519_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2009.02367.x","article-title":"Molecular mechanisims of drug resistance in status epilepticus","volume":"50","author":"Loscher","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2021.115519_bb0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2015.02.027","article-title":"Single versus combinatorial therapies in status epilepticus: novel data from preclinical models","volume":"49","author":"Loscher","year":"2015","journal-title":"Epilepsy Behav."},{"issue":"591","key":"10.1016\/j.taap.2021.115519_bb0240","first-page":"1","article-title":"Structural, molecular, nd functional alterations of the blood-brain barrier during Epileptogenesis and epilepsy: a cause, consequence, or both?","volume":"21","author":"Loscher","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2021.115519_bb0245","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","article-title":"Combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation","volume":"49","author":"Martin","year":"2008","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.taap.2021.115519_bb0250","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0028-3908(84)90241-7","article-title":"Effects of DFP on iridic metabolism and release of acetylcholine and on pupillary function in the rat","volume":"23","author":"Mattio","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2021.115519_bb0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractorystatus epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.taap.2021.115519_bb0260","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0149-7634(05)80151-4","article-title":"Pharmacological modulation of soman-induced seizures","volume":"17","author":"McDonough","year":"1993","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2\u20133","key":"10.1016\/j.taap.2021.115519_bb0270","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0091-3057(94)00372-P","article-title":"A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs","volume":"51","author":"McDonough","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.taap.2021.115519_bb0275","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.taap.2021.115519_bb0280","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in Guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.taap.2021.115519_bb0285","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115519_bb0290","series-title":"Review of nerve agent inhibitors and reactivators of acetylcholinesterase","author":"Moore","year":"1995"},{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0295","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1289\/ehp.9410218","article-title":"Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection","volume":"102","author":"Munro","year":"1994","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0300","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11064-007-9429-3","article-title":"Anticonvulsant efficacy of drugs with cholinergic and\/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman","volume":"33","author":"Myhrer","year":"2008","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic. Clin. Pharm."},{"key":"10.1016\/j.taap.2021.115519_bb0310","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2021.115519_bb0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.taap.2021.115519_bb0320","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"59","author":"Niquet","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2021.115519_bb0325","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.taap.2021.115519_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2019.104537","article-title":"Rational polytherapy in the treatment of cholinrgic seizures","volume":"133","author":"Niquet","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.taap.2021.115519_bb0335","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.44.10.1837","article-title":"Treatment of refractory generalized status epilepticus with continuous midazolam infusion","volume":"44","author":"Parent","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2021.115519_bb0340","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s40263-015-0289-0","article-title":"Intravenous and intramuscular formulations of antiseizure drugs in the treatment of epilepsy","volume":"29","author":"Patel","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.taap.2021.115519_bb0345","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.taap.2021.115519_bb0350","doi-asserted-by":"crossref","first-page":"104457","DOI":"10.1016\/j.nbd.2019.04.013","article-title":"Antioxidant drug therapy as a neuroprotective countermeasure of nerve agent toxicity","volume":"133","author":"Pearson-Smith","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.taap.2021.115519_bb0355","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/088307389801301201","article-title":"Use of Midazolam for refractory status epilepticus in pediatric patients","volume":"13","author":"Pellock","year":"1998","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.taap.2021.115519_bb0360","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.114.214932","article-title":"Animal models that best reproduce the clinical manifestations of human intoxication with organophosphorus compounds","volume":"350","author":"Pereira","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115519_bb0365","article-title":"Anticonvulsant therapy for status epilepticus (Review)","volume":"9","author":"Prasad","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0370","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/toxsci\/kfg166","article-title":"Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction","volume":"75","author":"Raveh","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2021.115519_bb0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.13160","article-title":"Neurosteroids for the potential protection of humans against organophosphate toxicity","volume":"1378","author":"Reddy","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/j.taap.2021.115519_bb0380","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7326\/M13-2799","article-title":"Lessons learned from the Syrian sarin attack: evaluation of a clinical syndrome through social media","volume":"160","author":"Rosman","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.taap.2021.115519_bb0385","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1474-4422(11)70187-9","article-title":"Management of refractory status epilepticus in adults: still more questions than answers","volume":"10","author":"Rossetti","year":"2011","journal-title":"Lancent. Neurol."},{"key":"10.1016\/j.taap.2021.115519_bb0390","first-page":"1","article-title":"Management of convulsions in nerve agent acute poisoning: A polish perspective","volume":"1","author":"Rump","year":"2004","journal-title":"J. Med. Chem. Def."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0395","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00432257","article-title":"Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain","volume":"78","author":"Shih","year":"1982","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0400","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0091-3057(99)00114-8","article-title":"Organophosphorus nerve agents induced seizures and efficacy of atropine sulfate as anticonvulsant treatment","volume":"64","author":"Shih","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.taap.2021.115519_bb0405","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cbi.2005.10.042","article-title":"In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents","volume":"157-158","author":"Shih","year":"2005","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0410","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/jpet.106.111252","article-title":"Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine","volume":"320","author":"Shih","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0415","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0269881107073199","article-title":"The open field test: reinventing the wheel","volume":"21","author":"Stabdford","year":"2007","journal-title":"J. Psycohopharmacol."},{"issue":"45","key":"10.1016\/j.taap.2021.115519_bb0425","doi-asserted-by":"crossref","first-page":"16423","DOI":"10.1523\/JNEUROSCI.2506-11.2011","article-title":"The anticonvulsant response to valproate in kindled rats is correlated with its effect on neuronal firing in the substatia nigra pars reticulata: a new mechanisim of pharmacoresistance","volume":"31","author":"Tollner","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2021.115519_bb0430","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0074-7742(06)81018-4","article-title":"Treatment of convulsive stasus epilepticus","volume":"81","author":"Treiman","year":"2007","journal-title":"Int. Rew. Neurobiol."},{"key":"10.1016\/j.taap.2021.115519_bb0435","series-title":"Pharmacotherapy for Status Epilepticus Drug","first-page":"1499","volume":"75","author":"Trinka","year":"2015"},{"key":"10.1016\/j.taap.2021.115519_bb0440","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcdb.2014.10.003","article-title":"Blood-brain barrier dysfunction, seizurs and epilepsy","volume":"38","author":"van Vlient","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"issue":"341","key":"10.1016\/j.taap.2021.115519_bb0445","first-page":"1","article-title":"Inflammation: a network in the pathogenesis of status epilepticus","volume":"11","author":"Wang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"Suppl. 8","key":"10.1016\/j.taap.2021.115519_bb0450","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1528-1167.2011.03243.x","article-title":"Rational polytherapy in the treatment of acute seizures and status epilepticus","volume":"52","author":"Wasterlain","year":"2011","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.taap.2021.115519_bb0455","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1471-4159.2003.01568.x","article-title":"Peripheral benzodiazepine receptors: on mice and human brain imaging","volume":"84","author":"Weissman","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2021.115519_bb0460","series-title":"Cholinesterase and Anticholinesterase Agents. Handbook of Experimental Pharmacology","article-title":"Pharmacological antagonists of the anticholinesterase agents","volume":"vol 15","author":"Wills","year":"1963"},{"issue":"2","key":"10.1016\/j.taap.2021.115519_bb0465","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.117.247106","article-title":"Midazolam-resistant seizures and brain injury following acute intoxication of diisopropylfluorophosphate, an organophosphate pesticide and surrogate for nerve agents","volume":"367","author":"Wu","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.taap.2021.115519_bb0470","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2006.06.007","article-title":"Sarin experiences in Japan: acute toxicity and long-term effects","volume":"249","author":"Yanagisawa","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.taap.2021.115519_bb0475","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuro.2006.04.006","article-title":"Our recent experiences with sarin poisoning cases in Japan and pesticide users with references to some selected chemicals","volume":"28","author":"Yokoyama","year":"2007","journal-title":"Neurotoxicology"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21001265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21001265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:54:56Z","timestamp":1758574496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21001265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":94,"alternative-id":["S0041008X21001265"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115519","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115519"}}